ArticleInternal medicine (Tokyo, Japan)2019

Hyperprogressive Disease in Lung Cancer with Transformation of Adenocarcinoma to Small-cell Carcinoma during Pembrolizumab Therapy.

Komugi Okeya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.